Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02523742
Other study ID # 05-097
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2005
Est. completion date April 23, 2015

Study information

Verified date August 2015
Source University Hospital, Caen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Recently, we have shown functional resonance imaging (fMRI) that variations in signal induced by a language task were significantly lower in a semantic region of the left hemisphere (comprised of that part pars triangularis of the inferior frontal gyrus and the temporal gyri medium and angular) in schizophrenic patients compared with controls matched for age, sex, level of education and handedness.

Investigators wish to test the hypothesis that functional modification of the hemispherical specialization is specific language and also specific for schizophrenia.


Recruitment information / eligibility

Status Completed
Enrollment 152
Est. completion date April 23, 2015
Est. primary completion date November 19, 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- patients under 65 years

- Schizophrenics, bipolar or schizoaffective (DSM IV)

- Patients who signed informed consent

Exclusion Criteria:

- Women with childbearing potential without effective contraception or positive pregnancy test.

- Contra-indications to fMRI

Study Design


Related Conditions & MeSH terms


Intervention

Device:
IMRf

Other:
language task and a reference task (rest and Tamil)


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Caen

Outcome

Type Measure Description Time frame Safety issue
Primary variation in signal (SPM99) during a language task compared to a reference task (rest or Tamil) in fMRI in anatomical regions of interest baseline
See also
  Status Clinical Trial Phase
Completed NCT05311878 - Non-invasive BCI for Cognitive Enhancement N/A